PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 103 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,935 | -5.7% | 24,690 | +26.6% | 0.00% | -33.3% |
| Q2 2023 | $68,835 | -36.2% | 19,500 | -44.1% | 0.00% | -25.0% |
| Q1 2023 | $107,841 | -45.6% | 34,900 | -25.5% | 0.00% | -63.6% |
| Q4 2022 | $198,108 | +73.8% | 46,834 | +18.0% | 0.01% | +120.0% |
| Q1 2022 | $114,000 | -17.4% | 39,700 | -12.6% | 0.01% | -44.4% |
| Q4 2021 | $138,000 | -40.5% | 45,400 | +97.4% | 0.01% | -80.9% |
| Q3 2020 | $232,000 | – | 23,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |